SciBase Holding ABOSTO:SCIB +0.30%50 Days Payable is 83.21 as of Mar. 2026, which is 56% below its 10-year median of 189.17. GuruFocus rates OSTO:SCIB with a GF Score™ of 50/100 and a GF Value™ of kr21.74 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, SciBase Holding AB ranks better than 70.94% on this metric.
The historical rank and industry rank for SciBase Holding AB's Days Payable or its related term are showing as below:
OSTO:SCIB'
s Days Payable Range Over the Past 10 Years
Min: 108.69 Med: 189.17 Max: 281.76
Current: 116.56
During the past 13 years, SciBase Holding AB's highest Days Payable was 281.76. The lowest was 108.69. And the median was 189.17.
OSTO:SCIB's Days Payable is ranked better than 70.94% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs OSTO:SCIB: 116.56
SciBase Holding AB's Days Payable
declined
from Mar. 2025 (222.47) to Mar. 2026 (83.21).
It may suggest that SciBase Holding ABaccelerated paying its suppliers.
SciBase Holding AB Days Payable Related Terms
SciBase Holding AB Days Payable Historical Data
* Premium members only.
The historical data trend for SciBase Holding AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SCIB vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, SciBase Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciBase Holding AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Days Payable distribution charts can be found below:
* The bar in red indicates where SciBase Holding AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SciBase Holding AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciBase Holding AB (OSTO:SCIB) has a Days Payable of 83.21 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SciBase Holding AB and its competitors. This is 56% below median its historical median of 189.17. Over the past decade, SciBase Holding AB's Days Payable has ranged from 108.69 to 281.76. According to the industry distribution chart, SciBase Holding AB ranks #231 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 29.1%.
Is SciBase Holding AB's Days Payable too high?
SciBase Holding AB's current Days Payable of 83.21 is 56% below median its 10-year median of 189.17. Over the past 10 years, this metric has ranged from a low of 108.69 to a high of 281.76. The Medical Devices & Instruments industry median Days Payable is 68.07. SciBase Holding AB's value of 83.21 is 22.2% above this industry median. Based on the distribution chart, SciBase Holding AB ranks #231 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SciBase Holding AB has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SciBase Holding AB ranks #231 out of 795 companies for Days Payable. This puts SciBase Holding AB in the upper half of its industry. The industry median Days Payable is 68.07. SciBase Holding AB's value of 83.21 is 22.2% above this benchmark. Historically, SciBase Holding AB's own Days Payable has ranged from 108.69 to 281.76 over the past decade. While the company's 10-year median is 189.17 vs. the industry median of 68.07, SciBase Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SciBase Holding AB's current Days Payable of 83.21 is 22.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SciBase Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SciBase Holding AB's current Days Payable is 83.21, which is 56% below median its own 10-year median of 189.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr21.74, compared to a current price of kr33.80 — trading 55.5% above its estimated fair value. The current Days Payable is 83.21, which is 56% below median its 10-year median of 189.17 and 22.2% above the Medical Devices & Instruments industry median of 68.07. SciBase Holding AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current Days Payable is 83.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?
Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued.
The current stock price of kr33.80 is trading 55.5% above its estimated GF Value™ of kr21.74.
GuruFocus considers SciBase Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:SCIB:
Days Payable: 83.21 (56% below median its 10-year median of 189.17)
GF Value™: kr21.74 vs. price of kr33.80 (55.5% above fair value)
Industry Position: 22.2% above the Medical Devices & Instruments median (#231 of 795)
No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
50GF Score
Get the complete analysis for OSTO:SCIB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SCIB has been successfully added to your 
